Evaluation of Access to Screening for Post-partum Depression Via the Postnatal Interview Within 8 Weeks of Birth in Women Who Have Gave Birth at the Troyes Hospital ( DEPRESSIONPP )

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorCentre Hospitalier de Troyes

About this trial

Post-partum depression is defined as a depressive disorder with onset of symptoms in the year following childbirth. Several international studies have reported a prevalence of this condition of around pathology of around 15%. Santé publique France's 2021 national perinatal survey corroborated these figures, finding a prevalence of post-partum depression in France of in France of 16.7%. It is therefore a frequent pathology that can cause complications for both mother and child.

The complications both for the mother and for the mother-child bond. Indeed, post-partum depression can lead to an increased risk of infanticide, weaker mother-child attachment, and altered parental behaviour. post-partum depression can lead to maternal suicide (the second leading cause cause of maternal mortality in France). Despite the potential seriousness of severe depression and its impact on the on the mother-child bond, just under half of those suffering from severe depression suffering from severe depression consult a healthcare professional.

Fear of being judged or stigmatised, linked to misperceptions about the episode, is one of the main obstacles to consultation.

Of being judged or stigmatised, linked to erroneous representations of the depressive episode. Given the scale of this condition, and the difficulties young mothers face in seeking help for young mothers to seek help, it is vital to screen postpartum women as widely and post-partum women as early as possible. In view of the extent of this condition and the difficulties young mothers have in seeking help for young mothers, it is vital to screen post-partum women as widely and as post-partum. With this in mind, from July 2022, a compulsory early post-natal interview has been introduced, designed to screen for postpartum depression.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

The study will include adult women who have given birth at the Centre hospitalier de Troyes from July 2022 to October 2023

and agreeing to take part in the study.

minors under the age of 18

those protected by law (guardianship, curatorship and safeguard of justice)

Disqualifiers

None

Trial population

the adult women who have given birth at the Centre Hospitalier de Troyes between July 2022 and October 2023.

Trial design

Design model

Other

Time perspective

Retrospective

Treatments tested in this trial

  • depression post partum

    Behavioral

    visit post partum

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Measure if the patient is yes or not to be referred by a healthcare professional during the early postnatal interview.

question

Time frame
3 months

Secondary outcomes

1

Measure the socio-economic status

financial parameter

Time frame
3 months
2

measure the declaration of a financial or non-financial obstacle

financial parameter

Time frame
3 months
3

measure the knowledge about post-partum depression

question first contact

Time frame
3 months
4

measure the knowledge about early post-natal interview.

question

Time frame
3 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.